Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Disease control in advanced Hodgkin lymphoma

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Improved OS with obinutuzumab in the CLL11 study

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018

Rituximab in combination therapies for FL: Interim results

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Mapping 3D genome dynamics in B cells

Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018

Update on bb2121 for relapsed myeloma

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )
4 Jun 2018

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018

Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation

Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation ( Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven )
4 Jun 2018

Developing a survivin vaccine for glioblastoma

Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Developing a survivin vaccine for glioblastoma ( Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
3 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation